Extended Treatment With PEG-Intron® and Rebetol® in Patients With Genotype 1 Chronic Hepatitis C and Slow Virologic Response (Study P03685)
Clinical trial NCT00265395 · COMPLETED
Trial details
- NCT number
- NCT00265395
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-12-01
- Primary completion
- 2008-05-01
- Enrollment
- 1428
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.